Company experienced a 24% stock price decline following disclosure of a $55 million charge related to ineligible arbitration claims, and is now subject to a securities investigation for potential violations of federal securities laws.
Nutex Health news
$210.10−1.24%
Close Sep 29, 2026 · split-adjustedArticles · 30 days0English, de-duplicated
Positive0
Neutral0
Negative0
About Nutex Health
GlobeNewswire Inc.Mar 10, 1:52 PM ET▼ Negative
Also mentions NUTX
Articles that tag NUTX but are mainly about other companies.
Zacks Investment ResearchAug 27, 10:05 AM ET▲ Positive
Zacks Rank #1, VGM Score A, 32.5% upward EPS revision for 2026, and beat consensus earnings by 82.13% in last quarter
GlobeNewswire Inc.Mar 17, 2:45 PM ET▼ Negative
Under investigation for potential securities fraud, suggesting investor losses and regulatory concerns
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology